Company research / ALT
Altimmune, Inc. (ALT)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Altimmune, Inc. reported revenue of $41.0K. Revenue grew 105.0% from the prior annual period.
Key ratios (year ended 2025-12-31)
n/m
Operating margin
n/m
Net margin
-39.2%
Return on year-end equity
105.0%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.